Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2015 1
2016 2
2017 2
2019 2
2020 7
2021 14
2022 17
2023 7
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacokinetic and Preclinical Safety Studies of Endolysin-Based Therapeutic for Intravenous Administration.
Antonova NP, Vasina DV, Grigoriev IV, Laishevtsev AI, Kapustin AV, Savinov VA, Vorobev AM, Aleshkin AV, Zackharova AA, Remizov TA, Makarov VV, Yudin SM, Gushchin VA. Antonova NP, et al. Among authors: gushchin va. Int J Antimicrob Agents. 2024 Sep 5:107328. doi: 10.1016/j.ijantimicag.2024.107328. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 39244166
Development of novel antimicrobials with engineered endolysin LysECD7-SMAP to combat Gram-negative bacterial infections.
Vasina DV, Antonova NP, Gushchin VA, Aleshkin AV, Fursov MV, Fursova AD, Gancheva PG, Grigoriev IV, Grinkevich P, Kondratev AV, Kostarnoy AV, Lendel AM, Makarov VV, Nikiforova MA, Pochtovyi AA, Prudnikova T, Remizov TA, Shevlyagina NV, Siniavin AE, Smirnova NS, Terechov AA, Tkachuk AP, Usachev EV, Vorobev AM, Yakimakha VS, Yudin SM, Zackharova AA, Zhukhovitsky VG, Logunov DY, Gintsburg AL. Vasina DV, et al. Among authors: gushchin va. J Biomed Sci. 2024 Jul 24;31(1):75. doi: 10.1186/s12929-024-01065-y. J Biomed Sci. 2024. PMID: 39044206 Free PMC article.
Pharmacokinetics and Preclinical Safety Studies of Modified Endolysin-based Gel for Topical Application.
Antonova NP, Vasina DV, Grigoriev IV, Usachev EV, Aleshkin AV, Vorobev AM, Laishevtsev AI, Kapustin AV, Savinov VA, Anurova MN, Zackharova AA, Remizov TA, Makarov VV, Yudin SM, Gushchin VA. Antonova NP, et al. Among authors: gushchin va. J Pharm Sci. 2024 Aug;113(8):2093-2100. doi: 10.1016/j.xphs.2024.04.028. Epub 2024 Apr 29. J Pharm Sci. 2024. PMID: 38692487
Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response.
Mazunina EP, Gushchin VA, Kleymenov DA, Siniavin AE, Burtseva EI, Shmarov MM, Mukasheva EA, Bykonia EN, Kozlova SR, Evgrafova EA, Zolotar AN, Shidlovskaya EV, Kirillova ES, Krepkaia AS, Usachev EV, Kuznetsova NA, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Mazunina EP, et al. Among authors: gushchin va. Front Immunol. 2024 Apr 16;15:1381508. doi: 10.3389/fimmu.2024.1381508. eCollection 2024. Front Immunol. 2024. PMID: 38690272 Free PMC article.
Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins.
Bykonia EN, Kleymenov DA, Gushchin VA, Siniavin AE, Mazunina EP, Kozlova SR, Zolotar AN, Usachev EV, Kuznetsova NA, Shidlovskaya EV, Pochtovyi AA, Kustova DD, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Bykonia EN, et al. Among authors: gushchin va. Vaccines (Basel). 2024 Apr 2;12(4):379. doi: 10.3390/vaccines12040379. Vaccines (Basel). 2024. PMID: 38675761 Free PMC article.
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses.
Siniavin AE, Gushchin VA, Shastina NS, Darnotuk ES, Luyksaar SI, Russu LI, Inshakova AM, Shidlovskaya EV, Vasina DV, Kuznetsova NA, Savina DM, Zorkov ID, Dolzhikova IV, Sheremet AB, Logunov DY, Zigangirova NA, Gintsburg AL. Siniavin AE, et al. Among authors: gushchin va. Antiviral Res. 2024 May;225:105871. doi: 10.1016/j.antiviral.2024.105871. Epub 2024 Mar 28. Antiviral Res. 2024. PMID: 38555022 Free article.
Evaluation of molecular mechanisms of riboflavin anti-COVID-19 action reveals anti-inflammatory efficacy rather than antiviral activity.
Akasov RA, Chepikova OE, Pallaeva TN, Gorokhovets NV, Siniavin AE, Gushchin VA, Savvateeva LV, Vinokurov IA, Khochenkov DA, Zamyatnin AA Jr, Khaydukov EV. Akasov RA, et al. Among authors: gushchin va. Biochim Biophys Acta Gen Subj. 2024 May;1868(5):130582. doi: 10.1016/j.bbagen.2024.130582. Epub 2024 Feb 8. Biochim Biophys Acta Gen Subj. 2024. PMID: 38340879
64 results